Invitrogen Acquire Dynal Biotech

Invitrogen Corporation has signed a definitive agreement to acquire Dynal Biotech, Dynal is a major supplier of specialized magnetic particles to major diagnostic product manufacturers for use in high-throughput automated immunoassay and other instrument systems.

Dynal's "smart" surface technology can be applied to many of Invitrogen's comprehensive product lines, and the company plans to use it to produce expanded sets of matched reagent solutions around genes, antibodies, enzymes, cell culture media and detection products.

These combined technologies will have applications in numerous areas of research, including stem cell and cell therapy applications, as well as in new products that support molecular diagnostics, and other key areas of research. In addition, Dynal is a market leader for tissue typing (HLA diagnostics) used to ensure compatibility between donors and recipients in organ and bone marrow transplants.